In the original article, there was a mistake in Figure 6D as published. The final submission for the SCD1 bands in Figure 6D was inadvertently truncated too short. The corrected Figure 6D appears below.
Figure 6
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
glioblastomas, temozolomide, resistance, SCD1, Akt signaling
Citation
Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, Li X, Sun L and Gong Z (2019) Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis. Front. Pharmacol. 10:1358. doi: 10.3389/fphar.2019.01358
Received
30 September 2019
Accepted
28 October 2019
Published
15 November 2019
Volume
10 - 2019
Edited by
Julie Gavard, Institut National de la Santé et de la Recherche Médicale (INSERM), France
Reviewed by
Julie Gavard, Institut National de la Santé et de la Recherche Médicale (INSERM), France
Updates
Copyright
© 2019 Dai, Yan, Xu, Zeng, Qian, Huo, Li, Sun and Gong.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhicheng Gong, gongzhicheng@csu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.